By analyzing information included in the registry, researchers found that younger patients, those with diabetes, and patients with diagnoses other than osteoarthritis (e.g. post-traumatic and rheumatoid arthritis) were at higher risk for revision total joint surgery. This information has been integrated into a risk calculator for surgeons and patients to use in making decisions about treatment. Research from the registry on implants and surgical techniques also has influenced changes in clinical practice, which have resulted in optimization of both techniques and implants.
"Within the United States, more than 600,000 total joint replacement procedures are performed each year, and the volume and costs associated with these procedures are projected to increase dramatically over the next 20 years," said Monti Khatod, MD, paper co-author and orthopedic surgeon at Kaiser Permanente in Baldwin Park, Calif. "Our registry allows health care professionals and other researchers to evaluate ways to be more efficient while enhancing quality and assessing new technology in order to determine which implants are best for our patients."
Authors of the paper include Elizabeth W. Paxton, MA<
SOURCE Kaiser Permanente
Copyright©2010 PR Newswire.
All rights reserved
Related medicine technology :
1. Kaiser Permanente - Group Health Study Shows Depression Worsens HIV Treatment
2. Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds
3. National Institutes of Health Awards More Than $54 Million to Kaiser Permanente to Conduct Health Research
4. Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results
5. Kaiser Permanente Launches Sustainability Scorecard for Medical Products
6. Home Health Monitoring May Significantly Improve Blood Pressure Control, Kaiser Permanente Study Finds
7. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
8. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
9. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety